Calciphylaxis: Treatment and outlook—CME part II

Jonathan Rick, Renajd Rrapi, Sidharth Chand, Michi M. Shinohara, Lindsay Strowd, Helena B. Pasieka, Robert Micheletti, Daniela Kroshinsky, Alex G. Ortega-Loayza

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations


Calciphylaxis is a rare and devastating condition with important systemic ramifications. This second-part of our CME aims to educate the practicing dermatologist on the current standard of care once a diagnosis of calciphylaxis is confirmed or highly suspected. The key pathologic findings, as well as the role and limitations of biopsy, are reviewed. We aim to guide readers through the complex hospitalization and posthospitalization management of these medically vulnerable patients. Collaboration with other specialists will be discussed. Experimental and developing treatments are discussed, and the outlook of the condition is reported.

Original languageEnglish (US)
Pages (from-to)985-992
Number of pages8
JournalJournal of the American Academy of Dermatology
Issue number5
StatePublished - May 2022


  • ESRD
  • calciphylaxis
  • calcium
  • clinical trials
  • palliative care
  • sodium thiosulfate

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Calciphylaxis: Treatment and outlook—CME part II'. Together they form a unique fingerprint.

Cite this